BiomX is a leading brand dedicated to developing natural and engineered phage therapies that target and eliminate harmful bacteria in chronic diseases. They specialize in creating customized phage cocktails designed to combat conditions such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer. BiomX's approach involves the discovery and validation of proprietary bacterial targets, which they then use to tailor phage compositions for maximum effectiveness.

The brand's innovative technology and platform for phage therapy development stem from collaborations with world-leading scientists from the Weizmann Institute of Science and MIT. With a robust pipeline spanning pre-clinical to phase III stages, BiomX is at the forefront of revolutionizing medicine with their cutting-edge solutions. Furthermore, they have established partnerships with industry leaders, including Janssen Pharmaceuticals and Boehringer Ingelheim, to further advance their research and discovery efforts.

Join the BiomX team and be part of their mission to develop the most advanced phage therapeutics